181 results
Page 6 of 10
6-K
EX-99.1
vtniz
26 Jun 19
Acasti Pharma Provides Fiscal 2019 Year-End Business Update
8:06am
6-K
EX-99.1
qmix9s6d ig8q2o3v4
24 Jun 19
Acasti Pharma Awarded Notice of Allowance for a Second Patent in China Covering CaPre’s Omega-3 Phospholipid Composition
9:01am
6-K
EX-99.1
mkzabb
19 Jun 19
Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call
8:00am
6-K
EX-99.1
wxllce1 sl5ylof4lw
4 Jun 19
Acasti Pharma Announces TRILOGY 2 Trial Has Achieved its 100% Patient Randomization Target in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
gsp59d9im1z4x0
21 May 19
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
7:31am
6-K
EX-99.1
3fayyw 7850qmu7gqd
15 May 19
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
7:56am
6-K
EX-99.1
g3k73y8zjfk0qbhn3
10 May 19
Current report (foreign)
10:05am
6-K
EX-99.1
ywtt10ux
24 Apr 19
Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
8:35am
6-K
EX-99.1
onttcar8
15 Apr 19
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
9:15am
6-K
EX-99.1
am59 ho714pxk3
26 Mar 19
Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
8:30am
6-K
EX-99.1
rd1bz3dfcf8j4j7
13 Mar 19
Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
8:30am
6-K
EX-99.1
ojrbhbt hcqf2r
21 Feb 19
Current report (foreign)
9:15am
424B5
uhmy80 mas
14 Feb 19
Prospectus supplement for primary offering
8:06am
6-K
EX-99.1
p6zy9 26qrvy3
14 Feb 19
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
8:05am
6-K
EX-99.1
6b8qyo1213vg
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.2
z5dwxr xg6
14 Feb 19
Current report (foreign)
7:55am
6-K
EX-99.1
07t7632wxig0j7q9
8 Feb 19
Acasti Pharma Schedules Third Quarter Fiscal 2019 Conference Call
8:05am
6-K
EX-99.1
azb7h4x0 5i
9 Jan 19
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
8:05am
6-K
EX-99.1
th91k1ib7
31 Dec 18
Current report (foreign)
8:00am
6-K
EX-99.1
m3h8aemp11
20 Dec 18
Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia
8:01am